Belgium's former King Albert II has undergone cancer treatment for the sixth time in 11 years, the Belgian Palace has ...

TIL-IMP therapy offers sustained QoL benefits over ipilimumab in advanced melanoma, supporting its role in personalized care.

How woman beats terminal cancer after doctors gave up hope. Sarah Martinez's incredible journey will inspire you to never ...

When Katie Doble was diagnosed with a rare cancer, she was given 16 months to live. Clinical trials gave her a second chance.

Pathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The ...

A single mom recently posted a PSA on TikTok after a seemingly benign imperfection turned out to be cancer. Rachel, 33, had a ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

Rare, deadly, and often missed, some skin cancers develop in areas that rarely see the sun. Scientists are still learning about them, but here's what we know.

We're talking with Dr. Richard Miller, founder of Bay Dermatology, at their Downtown St. Pete location to discuss Mohs ...

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.